These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12090409)

  • 21. Causal mediation analysis with multiple mediators in the presence of treatment noncompliance.
    Park S; Kürüm E
    Stat Med; 2018 May; 37(11):1810-1829. PubMed ID: 29542166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bayesian phase II clinical trial design with noncompliance.
    Ren T; Shen W; Zhang L; Zhao H
    Stat Med; 2021 Sep; 40(20):4457-4472. PubMed ID: 34050539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using the instrumental variables estimator to analyze noninferiority trials with noncompliance.
    Kim MY
    J Biopharm Stat; 2010 Jul; 20(4):745-58. PubMed ID: 20496203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Handling missing data in randomized experiments with noncompliance.
    Jo B; Ginexi EM; Ialongo NS
    Prev Sci; 2010 Dec; 11(4):384-96. PubMed ID: 20379779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of statistical methods for analysing survival data in the presence of non-random compliance.
    Odondi L; McNamee R
    Stat Med; 2010 Dec; 29(29):2994-3003. PubMed ID: 20963732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond intent to treat (ITT): A complier average causal effect (CACE) estimation primer.
    Peugh JL; Strotman D; McGrady M; Rausch J; Kashikar-Zuck S
    J Sch Psychol; 2017 Feb; 60():7-24. PubMed ID: 28164801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation.
    Greenland S; Lanes S; Jara M
    Clin Trials; 2008; 5(1):5-13. PubMed ID: 18283074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Causal logistic models for non-compliance under randomized treatment with univariate binary response.
    Ten Have TR; Joffe M; Cary M
    Stat Med; 2003 Apr; 22(8):1255-83. PubMed ID: 12687654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Model misspecification sensitivity analysis in estimating causal effects of interventions with non-compliance.
    Jo B
    Stat Med; 2002 Nov; 21(21):3161-81. PubMed ID: 12375297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overview of statistical methods for handling nonadherence to intervention protocol in randomized control trials: a methodological review.
    Mostazir M; Taylor RS; Henley W; Watkins E
    J Clin Epidemiol; 2019 Apr; 108():121-131. PubMed ID: 30528792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stratified analysis in randomized trials with noncompliance.
    Matsui S
    Biometrics; 2005 Sep; 61(3):816-23. PubMed ID: 16135033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Test equality and sample size calculation based on risk difference in a randomized clinical trial with noncompliance and missing outcomes.
    Lui KJ; Chang KC
    Biom J; 2008 Apr; 50(2):224-36. PubMed ID: 18264992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Complier Average Causal Effect Parameter for Multiarmed RCTs.
    Schochet PZ
    Eval Rev; 2020 Oct; 44(5-6):410-436. PubMed ID: 33375826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of the risk difference under a noncompliance randomized clinical trial with missing outcomes.
    Lui KJ
    J Biopharm Stat; 2008; 18(2):273-92. PubMed ID: 18327721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there another way to take account of noncompliance in randomized controlled trials?
    Hewitt CE; Torgerson DJ; Miles JN
    CMAJ; 2006 Aug; 175(4):347. PubMed ID: 16908892
    [No Abstract]   [Full Text] [Related]  

  • 36. Noncompliance in lifestyle intervention studies: the instrumental variable method provides insight into the bias.
    Hertogh EM; Schuit AJ; Peeters PH; Monninkhof EM
    J Clin Epidemiol; 2010 Aug; 63(8):900-6. PubMed ID: 20189770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating causal effects from a randomized clinical trial when noncompliance is measured with error.
    Boatman JA; Vock DM; Koopmeiners JS; Donny EC
    Biostatistics; 2018 Jan; 19(1):103-118. PubMed ID: 28605411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analyzing a randomized trial on breast self-examination with noncompliance and missing outcomes.
    Mealli F; Imbens GW; Ferro S; Biggeri A
    Biostatistics; 2004 Apr; 5(2):207-22. PubMed ID: 15054026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical implications of noncompliance in randomized clinical trials for temporomandibular disorders.
    Whitney CW; Dworkin SF
    J Orofac Pain; 1997; 11(2):130-8. PubMed ID: 10332319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accounting for variability in sample size estimation with applications to nonadherence and estimation of variance and effect size.
    Fay MP; Halloran ME; Follmann DA
    Biometrics; 2007 Jun; 63(2):465-74. PubMed ID: 17688499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.